📋 Tender Overview
EIB
Impress is a leading invisible orthodontics and HealthTech company operating across 9 European markets.
The EIB loan will drive the development of Impress’s artificial intelligence (AI) platform and accelerate the company’s expansion plans across Northern European markets.
Backed by InvestEU, this venture debt financing supports the EIB’s strategic priority to boost technological innovation and digitalization in Europe.
The European Investment Bank (EIB), part of the European Investment Bank Group (EIB Group), has signed a €40 million venture debt loan with Impress, a leading digital orthodontics network in Europe which operates over 110 clinics worldwide.
The EIB financing will enable Impress to scale up investments in AI and strengthen its proprietary technology platform for the diagnosis and treatment of clear aligner patients. The loan will also accelerate the company’s expansion plans across Northern Europe.
The project features a strong technological focus, allowing Impress to reinforce its comprehensive, AI-driven healthcare ecosystem. This ecosystem seamlessly integrates patient scanning, treatment planning, and continuous monitoring. The solution spans from in-clinic 3D intraoral scans -delivering more accurate tooth-movement predictions than traditional molds - to AI-assisted treatment planning to ongoing patient tracking via Impress’s proprietary mobile app. Following its consolidation in Southern Europe, the company’s next growth phase will target the north of the continent, focusing on strategic markets including Germany, the Netherlands, and the United Kingdom.
“The digital transformation of the healthcare sector offers significant opportunities to improve the quality and efficiency of services provided to citizens. This operation reflects the EIB’s commitment to supporting innovative European growth companies like Impress that leverage AI to build cutting-edge solutions and expand their footprint across Europe, reinforcing EU leadership in HealthTech innovation,” stated María Romano, Head of the EIB Group Office in Spain.
“For years, patients have had to choose between expensive orthodontics with constant clinic visits, or at-home solutions without adequate medical follow-up. At Impress, we were born to close that gap. Our technology features an artificial intelligence engine powered by a global database of 500,000 patients, which allows us to multiply the efficiency of our clinics ten times, reduce in-person visits by 80%, and make quality medical care more accessible. The backing of the EIB represents a seal of guarantee in the HealthTech companies’ ecosystem in Europe, confirms our vision, and places us in an advantageous position to consolidate our model in Europe” said Vladimir Lupenko, Co-founder and CEO of Impress.
The financing agreement supports the EIB’s strategic priority of fostering technological innovation and digitalization, one of the eight core priorities outlined in the EIB Group’s Strategic Roadmap for 2024–2027. Specifically the project advances the Group’s initiatives in HealthTech, where it serves as a European benchmark. It also contributes to TechEU, the EIB Group program aimed at accelerating EU innovation, which seeks to mobilize €250 billion in investments by 2027 for startups, scaleups, and innovative companies across Europe. The EIB loan is guaranteed by InvestEU, the European Union’s flagship program designed to mobilize public and private investment in support of EU policy goals.
Background information
EIB Group
The European Investment Bank Group (EIB Group) is the financing arm of the European Union, owned by the 27 Member States, and one of the largest multilateral development banks in the world. In 2025, the EIB Group signed €100 billion in new financing and advisory services for over 870 high-impact projects under its eight core priorities that support EU policy objectives: climate action and the environment, digitalisation and technological innovation, security and defence, territorial cohesion, agriculture and the bioeconomy, social infrastructure, global partnerships and the savings and investments union. Beyond long-term loans for large-scale infrastructure, the EIB Group crowds in private investment for high-risk innovative projects and businesses, with a growing role in Europe’s markets for venture debt, venture capital, guarantees and securitisations.
In Spain, the EIB Group signed new financing worth €12.3 billion for over 100 high-impact projects in 2024, contributing to the country’s green and digital transition, economic growth, competitiveness and better services for its people.
The European Investment Fund (EIF) is the subsidiary of the EIB Group specialised in providing guarantees, securitisations and equity to improve access to finance for SMEs and startups across Europe. Acting as an anchor investor, through its extensive network of partnering banks and investment funds, the EIF mobilises private investment and nurtures the ecosystem of venture capital funds to support innovative European entrepreneurs. With the support of the 27 EU Member States, the EIF has, together with institutional investors, created a pan-European alliance to mobilise up to €80 billion in investments with the purpose of ensuring that innovative companies become global leaders. This joint effort will expand both the volume and the scope of the successful European Tech Champions initiative (ETCI), which, since its launch three years ago, has contributed to the creation of 15 European mega-funds and the growth of 50 companies, including 15 unicorns.
Photos of the EIB Group management and headquarters, logo files and video B-roll for media use are available here.
InvestEU
The InvestEU programme provides the European Union with crucial long-term funding by leveraging substantial private and public funds in support of a sustainable recovery. It also helps crowd in private investment for the European Union’s policy priorities such as the European Gree
